Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Low-molecular-weight chromium-binding substance (chromodulin) is a small oligopeptide that binds chromium ions and regulates insulin receptor activity, with unclear structure and mechanism, not a conventional therapeutic target[1][2][3][4][5][6][7].
Potentiates insulin receptor activity; Facilitates tissue chromium uptake
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Low-molecular-weight chromium-binding substance (LMWCr (chromodulin)).